<div>Researchers in the United States and India have conducted a study demonstrating the real-world effectiveness of a single dose of Johnson &amp; Johnson’s Ad26.COV2.S vaccine at preventing infection with severe acute respiratory syndrome coronavirus 2 – the agent that causes coronavirus disease 2019 (COVID-19).</div>